Synthesis of the novel mannosidase inhibitors (3R)- and (3S)-3-(hydroxymethyl)swainsonine

Add time:09/09/2019    Source:sciencedirect.com

Swainsonine (9) is an important mannosidase inhibitor that has been examined clinically as an anticancer drug. The preparation of analogs of swainsonine bearing a hydroxymethyl group at C(3), i.e., (3R)-3-(hydroxymethyl)swainsonine [(10), (3R)-HMS] and (3S)-3-(hydroxymethyl)swainsonine [(11), (3S)-HMS] is described. The synthesis of each analog begins with D-ribose, and involves a Claisen rearrangement, a Sharpless osmylation, and a reductive double-cyclization of either an azido mesylate bearing a lactone (i.e. 24 ⇒ 11) or an azido epoxide bearing a lactone (i.e. 27 ⇒ 10). Both (3R)-HMS and (3S)-HMS were found to be effective inhibitors of α-mannosidase from jack bean.

We also recommend Trading Suppliers and Manufacturers of (3R)-2,3-Dihydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-10H-3α,10aα-epidithiopyrazino[1,2-a]indole-1,4-dione (cas 1668-07-1). Pls Click Website Link as below: cas 1668-07-1 suppliers

Prev:Convenient synthesis of (2S,3R,4R,5S,6R)-2-(3-(4-ethylbenzyl)-4-chlorophenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol
Next:Synthesis of three branched iminosugars [(3R,4R,5S)-3-(hydroxymethyl)piperidine-3,4,5-triol, (3R,4R,5R)-3-(hydroxymethyl)piperidine-3,4,5-triol and (3S,4R,5R)-3-(hydroxymethyl)piperidine-3,4,5-triol] and a branched trihydroxynipecotic acid [(3R,4R,5R)-3,4,5-trihydroxypiperidine-3-carboxylic acid] from sugar lactones with a carbon substituent at C-2)